DK2105135T3 - Farmaceutiske sammensætninger til behandling af cancer - Google Patents
Farmaceutiske sammensætninger til behandling af cancerInfo
- Publication number
- DK2105135T3 DK2105135T3 DK09008756.0T DK09008756T DK2105135T3 DK 2105135 T3 DK2105135 T3 DK 2105135T3 DK 09008756 T DK09008756 T DK 09008756T DK 2105135 T3 DK2105135 T3 DK 2105135T3
- Authority
- DK
- Denmark
- Prior art keywords
- cancer
- treatment
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/4035—Isoindoles, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
- A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38084202P | 2002-05-17 | 2002-05-17 | |
| US42460002P | 2002-11-06 | 2002-11-06 | |
| EP03728969A EP1505973B1 (en) | 2002-05-17 | 2003-05-16 | Combinations for treating multiple myeloma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2105135T3 true DK2105135T3 (da) | 2014-11-03 |
Family
ID=49449200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK09008756.0T DK2105135T3 (da) | 2002-05-17 | 2003-05-16 | Farmaceutiske sammensætninger til behandling af cancer |
Country Status (4)
| Country | Link |
|---|---|
| CA (2) | CA2855306A1 (da) |
| DK (1) | DK2105135T3 (da) |
| NZ (1) | NZ595125A (da) |
| SI (1) | SI2105135T1 (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201806322QA (en) * | 2016-01-25 | 2018-08-30 | Regeneron Pharma | Maytansinoid derivatives, conjugates thereof, and methods of use |
-
2003
- 2003-05-16 CA CA2855306A patent/CA2855306A1/en not_active Abandoned
- 2003-05-16 DK DK09008756.0T patent/DK2105135T3/da active
- 2003-05-16 NZ NZ595125A patent/NZ595125A/xx not_active IP Right Cessation
- 2003-05-16 CA CA2855359A patent/CA2855359A1/en not_active Abandoned
- 2003-05-16 SI SI200332400T patent/SI2105135T1/sl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ595125A (en) | 2013-10-25 |
| CA2855306A1 (en) | 2003-11-27 |
| CA2855359A1 (en) | 2003-11-27 |
| SI2105135T1 (sl) | 2015-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2015003I1 (el) | Φαρμακευτικες συνθεσεις για θεραπεια καρκινου | |
| IS7691A (is) | Lyfjasamsetningar til að meðhöndla æxli | |
| IS8398A (is) | Lyfjasamsetningar til að meðhöndla æxli | |
| DK1420759T3 (da) | Farmaceutiske sammensætninger til behandling af astma | |
| IS8125A (is) | Kínasólínafleiður til að meðhöndla krabbamein | |
| DK1765391T3 (da) | Bakterielle præparater til behandlingen af cancer | |
| DK1803718T3 (da) | 4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter | |
| DK1868579T3 (da) | Farmaceutisk sammensætning omfattende en omega-carboxyaryl sunstitueret diphenylurea til behandling af cancer | |
| DK1701941T3 (da) | Forbindelser til behandling af sygdomme med celleproliferation | |
| DK1716119T3 (da) | Analoger af benzoquinonholdige ansamyciner til behandling af cancer | |
| DK1644021T3 (da) | Fremgangsmåder og sammensætninger til behandlingen af gastrointestinale sygdomme | |
| CY2013022I1 (el) | Συνθεσεις για την θεραπευτικη αγωγη γαστρεντερικων διαταραχων | |
| DK1656347T3 (da) | Substituerede indolderivater til farmaceutisk sammensætning til behandling af luftvejssygdomme | |
| FI20011478A0 (fi) | Farmaseuttinen koostumus | |
| DK1450606T3 (da) | Synergistiske sammensætninger til behandling af såsæd | |
| DK1353668T3 (da) | Fremgangsmåder til fremstillingen af farmaceutiske sammensætninger, der indeholder epothilonanaloger, til behandlingen af cancer | |
| DK1499730T3 (da) | Immunokonjugater til behandling af tumorer | |
| PT1467724E (pt) | Composicao farmaceutica orodispersavel de agomelatina | |
| DK1448205T3 (da) | Kombinationer til behandling af immunoinflammatoriske sygdomme | |
| NO20053348D0 (no) | Farmasoytisk sammensetning for behandling av virusangrep. | |
| EE200300589A (et) | Ravimkoostised | |
| FI20022128A0 (fi) | Farmaseuttinen koostumus | |
| DK1687297T3 (da) | Triazindimerer til behandling af autoimmunsygdomme | |
| DK1503747T3 (da) | Diclofenacbaseret sammensætning til topisk behandling af sygdomme | |
| DK1511724T3 (da) | Fremgangsmåde til fremstilling af thioalkylaminderivater |